海外保持高增长，拓展 AI 智能穿戴设备 鱼跃医疗(002223) 鱼跃医疗 2025Q3 业绩点评 | [Table_Finance] 财务摘要(百万元) | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入 | 7,972 | 7,566 | 8,480 | 9,596 | 10,870 | | (+/-)% | 12.3% | -5.1% | 12.1% | 13.2% | 13.3% | | 净利润(归母) | 2,396 | 1,806 | 1,982 | 2,286 | 2,646 | | (+/-)% | 50.2% | -24.6% | 9.8% | 15.3% | 15.7% | | 每股净收益(元) | 2.39 | 1.80 | 1.98 | 2.28 | 2.64 | | 净资产收益率(%) | 20.4% | 14.4% | 14.1% | 14.4% | 14.7% | | 市盈率(现价&最新股本摊薄) | 14.92 | 19.80 | 18.04 | 15. ...